Evaluation of Biologic Efficacy and Cost per NNT in Moderate-to-Severe Psoriasis: Indian Analysis Dr. Bhumika Maikhuri22 Jan 2026 10:30 AM ISTEvaluation of Biologic Efficacy and Cost per NNT in Moderate-to-Severe Psoriasis: Indian Analysis. Ixekizumab and ustekinumab were the most...
U.S. FDA Grants Approval for Ranitidine Comeback Medical Dialogues Team20 Jan 2026 10:48 AM ISTDecember 6, 2025: The U.S. Food and Drug Administration (US FDA) in November 2025 has approved reformulated ranitidine tablets, marking the return of...
Dapagliflozin and Sitagliptin FDC in T2D with Heart Failure: 2025 Indian Practice Review Dr. Santosh H.S.17 Jan 2026 11:39 AM ISTAmong India's 89.8 million people with T2D [1], heart failure incidence reaches approximately 50%, with 33% higher hospitalization risk versus...
Importance of Early Aggressive Glucose Control - Approach in 2026 Dr. Bhumika Maikhuri15 Jan 2026 11:15 AM ISTIn this episode of The Diabetes Wellness Forum, titled "Importance of Early Aggressive Glucose Control-Approach in 2026," Dr Nandita Mohan from...
The 1st Tooth Crosstalk | Episode 2 | Brush Early Brush Right - Practical Pearls for Clinicians Swapnil Sharma13 Jan 2026 10:58 AM ISTWe bring you Episode 2 of The 1st Tooth Crosstalk: Brush Early Brush Right - Practical Pearls for Clinicians.In this episode, we are joined by two...
FOGSI Expert Consensus Review Redefines Landscape of Endometriosis Management with Elagolix: 5 Key Takeaways Swapnil Sharma12 Jan 2026 11:30 AM ISTEndometriosis is a chronic, estrogen-dependent condition affecting an estimated 10% of women of reproductive age worldwide and is a leading cause of...
Latest Triple Combination of Empagliflozin, Sitagliptin, and Metformin for Advanced Care in Indian T2DM Patients- When to Consider? Dr. (Col) Sudhir Tripathi9 Jan 2026 11:37 AM ISTDiabetes mellitus affects nearly 90 million Indians (IDF 2025) [1], with the Indian phenotype conferring disproportionately higher cardiorenal risk...
Abemaciclib's New Overall Survival Data in Early Breast Cancer: Findings from MonarchE trial Dr. Bhumika Maikhuri8 Jan 2026 12:00 PM ISTIn this short video, Prof Stephen Johnston, Consultant Medical Oncologist, Royal Marsden Hospital and Institute of Cancer Research, London, ...
Abemaciclib Delivers New Overall Survival Data in Early Breast Cancer Patients Medical Dialogues Team7 Jan 2026 10:45 AM ISTIn this short video, Prof Stephen Johnston, Consultant Medical Oncologist, Royal Marsden Hospital and Institute of Cancer Research, London, ...
New Book on Early Breast Cancer Released at ISMPO Congress: A Comprehensive, Evidence-Based Guide for Clinicians Medical Dialogues Team2 Jan 2026 10:30 AM ISTThe Indian Society of Medical and Pediatric Oncology (ISMPO) Congress which was recently held in Jaipur saw the launch of a major new resource,...
Early-Onset Hypertension and Elevated ASCVD Risk: When Does Aspirin Fit? Dr. Laxman Gaikwad1 Jan 2026 11:30 AM ISTThe epidemiology of hypertension in India has undergone a malignant shift, moving from a disease of the elderly to a pervasive condition in the...
Humanized Medicine in 2026 Dr. Bhumika Maikhuri1 Jan 2026 11:15 AM ISTAs health systems worldwide enter a new year marked by rapid technological expansion, rising costs, and ageing populations, a fundamental question...
